The study was designed as a quasi-experimental, 24-week outdoor exercise program and 12-week follow-up in persons with schizophrenia from Porto city, Portugal (Figure 1). This protocol follows the Standard Protocol Items: Recommendations for Interventional Studies (SPIRIT) 2013 checklist (20).
Trial design
This study is a multicenter quasi-experimental controlled trial with a parallel design, that will be conducted in different public and private settings (e.g., general hospitals, psychiatric hospitals, day-care centers and local community centers) for outpatients. Advertisements will be made via phone calls and presential. In order to motivate participants about the exercise sessions, a short presentation session will be provided to exemplify and illustrate a typical session.
Eligible participants will receive a complete explanation of the study purposes, risks and procedures. Following rigorous ethical procedures, informed consent will be obtained from interested participants. After agreeing to participate and according to availability, participants will be allocated into a 24-week experimental group (EG) or into the control group (CG) (see Figure 1). All CG participants will follow with the usual daily routine.
Participants (EG) will be assessed at baseline, after 24-week of intervention, and 12-week follow-up after the end of intervention (Table 1). At baseline, sociodemographic (e.g., age and years of formal education and general clinical data (e.g., presence of comorbidities, pharmacological treatment) will be collected through a structured self-reported questionnaire. Mental health measures, such as self-esteem (Rosenberg Self-esteem), motivation for exercise (Behavioural Exercise Regulations Questionnaire) and quality of life (WHOQOL-Brief) will be assessed using different self-reported questionnaires. Physical health measures such as functional exercise capacity (6-minute walking test), physical fitness (Eurofit) and physical activity levels (GTX3) will be assessed by different field tests.
The standard software ActiLife version 6.9 (Actigraph, Florida) will be use to reduce the raw activity data from the GTX3 triaxial accelerometer into daily PA. A minimum recording of 8-h/day will be the criteria to accept daily PA data as valid. Individual data will only accept for analysis if at least three days of 480 minutes will be successfully assessed. To determine the time spent in PA of different intensities, the following counts intervals (counts/min) will be considered: sedentary physical activity (SEDPA) from 0 to 99 counts/min, for light physical activity (LIGPA) 100 to 2019, 2020 to 5998 for moderate physical activity (MODPA) and ≥5999 for vigorous physical activity (VIGPA) (21).
Data collection will be performed by well-trained and experienced researchers. The same evaluator will be responsible to perform the same procedures along the three assessment periods.
Table 1. Schedule of study protocol
Month
|
Jan
|
Fev
|
Mar
|
Apr
|
May
|
Jun
|
Jul
|
Aug
|
Set
|
Oct
|
|
Day of the month
|
Bike Approach
|
12
|
2
|
|
|
|
|
|
|
|
|
Baseline Assessments
|
|
2 to 14
|
|
|
|
|
|
|
|
|
Intervention
|
|
14
|
|
|
|
|
27
|
|
|
|
Post-program assessments
|
|
|
|
|
|
|
27 to 29
|
|
|
|
Follow-up
|
|
|
|
|
|
|
29
|
|
|
21
|
Follow-up assessments
|
|
|
|
|
|
|
|
|
|
21 a 28
|
|
Jan= January; Feb= February; Mar= March; Apr= April; Jun= June; Jul= July; Aug= August; Set= September Oct= October
|
Participants
Eligibility criteria
Inclusion criteria will include outpatients with schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders – 5 (DSM-5) (22) in a stable clinical situation with no changes in the antipsychotic medication for one month prior to the program, aged between 18 to 60 and living in the community.
The exclusion criteria for this study will include: inability to speak and understand Portuguese, inability to concentrate for at least 20 minutes (as determined by the treating psychiatrist), substance use disorder or recent substance use within the past six months, hospitalization within the preceding three months, uncontrolled psychiatric symptoms, diagnosis of intellectual disability, and presence of cardiovascular (e.g., uncontrolled hypertension defined as systolic blood pressure >200 mmHg or diastolic blood pressure >110 mmHg, cardiac comorbidities), respiratory (e.g., severe chronic obstructive pulmonary disease, uncontrolled asthma), neuromuscular, and endocrine (e.g., uncontrolled diabetes) disorders that may contraindicate exercise.
Study intervention
Experimental group: exercise training
A 24-week outdoor exercise program will comprise 50 minutes sessions twice a week. The outdoor exercise program will combine walking (or jogging, short runs) and cycling (in different speed) using the facilities nearby the Faculty of Sport, which include green spaces and a park with a small course of water and different kinds of road pavement. Every session will be performed outdoors in small groups. In case of bad weather conditions, the exercise will be conducted indoor using the treadmill and stationary bike located in faculty gym.
In the first 12-weeks, participants will spend 10 minutes setting daily goals and performing warm-up exercises such as knee lifts, squats, lunges with long strides, heel lifts, and stretching. This will be followed by 30 to 35 minutes of walking or biking at a maximum heart rate of 65% to 75%, and finally, 10 minutes for cool-down exercises and discussing the day's achievements. Over the final 12 weeks, the routine will start with 5 minutes dedicated to setting daily goals and warming up, followed by 10 minutes of physical fitness exercises such as squats, lunges, sit-ups, planks, and balancing on one leg. Then, there will be 30 minutes allocated for walking or biking with a maximum heart rate of 75%-85%, and the last 10 minutes will be for cooling down and reflecting about the day's accomplishments.
The research team will closely monitor and regulate the duration and intensity of the exercise program, encouraging participants to enhance their compliance and attendance. Initially, for the first 12 weeks, activities will be prescribed at 65%-75% of maximum heart rate, tracked using portable heart rate monitors worn by participants during each session (Garmin Vívosmart 4). After this period, intensities will rise to 75%-85% of maximum heart rate, remaining consistent until the program's conclusion. To assess participants' perceived exertion, the Borg scale will be employed after each session. Additionally, participants will review and adjust their personal goals with the research team before and after sessions to enhance mood and motivation (19).
Experimental group: 12-week follow-up
During the follow-up period, participants will receive encouragement to engage in exercise through frequent but brief phone interactions with the exercise professional. While weekly exercise supervision will not be provided, participants are encouraged to utilize the same public green spaces for their physical activities. Adherence to the 12-week follow-up will be assessed by querying participants about their continued exercise routines, including the frequency and type of exercise maintained. Adherence will be defined as participating in at least one activity per week.
Control group
Participants will follow their regular routine. However, participants who eventually engage in new activities or interventions must advise the researchers. Participants of this group will be contacted by the researcher to perform all the assessment moments of the study.
Outcomes
Physical outcomes will be evaluated by the six-minute walking test (6MWT) to estimate the functional exercise capacity of the participants. The participants will walk as much as possible for six minutes on a specific flat surface, and their changes will be recorded based on the distance covered in meters (23, 24). The Eurofit test battery will be applied to evaluate the participants’ physical fitness (25) and will include assessments of whole body balance (flamingo balance), speed of limb movement (plate tapping), flexibility (sit-and-reach), explosive strength (standing board jump), static strength (hand grip strength), abdominal muscular endurance (sit-ups) and running speed (shuttle run) (26, 27). Lastly, the GTX3 triaxial accelerometer (Actigraph, Florida) will be utilized to objectively measure habitual PA. Participants will be instructed to wear the accelerometer for 7 consecutive days, positioning it on the right hip using an adjustable belt. Exceptions will be made for time spent sleeping and engaging in showering or other water activities. Participants will be advised to maintain their usual activity routines. Validity criteria will require at least 3 days with 480 minutes of recorded activity.
Regarding anthropometric measures, height will be measure using a Holtain stadiometer (Holtain Ltd., Crymmych, UK) and record in centimetres. Weight will be measure to the nearest 0.1 kg with a Seca weight scale. Body mass index (BMI) will be calculated by the ratio between weight and height (kg/m2). Participant waist and hip circumference will be taken.
The mental health outcomes will be assessed by Rosenberg self-esteem questionnaire validated for Portugal (28). Rosenberg Self-Esteem Scale is a 4-point scale consisting of 10 questions, 5 positive and 5 negative with scores ranging from 10 to 40. Higher scores indicate better self-esteem (28). The reliability was evaluated among outpatients with severe mental disorders, demonstrating an internal consistency exceeding 0.80 (29). The Behavioural Exercise Regulations Questionnaire (BREQ-3) consists of six subscales assessing amotivation, external, introjected, identified, integrated regulation and intrinsic motivation (30, 31) and will be used to assess the participants’ motivation for exercise. The validity and reliability of the Portuguese version of the BREQ-3 (32) was confirmed for individuals with schizophrenia, indicating its suitability as an assessment tool for this population. Also, the Portuguese version of the World Health Organization Quality of Life Scale – Brief Version (WHOQOL – Brief) (33) will be used. The WHOQOL – Brief includes 26 items categorized into four domains: (i) physical; (ii) physiological; (iii) social relationships; (iv) environment and two questions related to global perception of quality of life and health. The Portuguese adaptation of the WHOQOL-BREF demonstrated strong validity and reliability, with a correlation coefficient of 0.65 and a Cronbach's alpha of 0.92 (33).
Confounders
As possible confounders, we will control the demographic variables (e.g., age, gender, education, marital status, employment), the clinical variables like the years of psychiatric disorder, psychotropic medication and smoking (cigarettes/day).
Statistical analysis
Descriptive statistics will be taken for normality, means and standard deviations. Differences between groups at baseline will be assess using the independent-samples student’s t-tests for continuous variables and Ficher’s exact test for categorical variables. The student’s t-test for paired samples and Wilcoxon test will be used to determine changes within the groups from baseline to post-program. Correlation will be analysed using Pearson’s correlation coefficient. A repeated-measures ANOVA with Bonferroni adjustments will be used to compare changes in the outcomes between treatments over time (treatment x time) as appropriate. All analysis will be computed with SPSS (version 27) with the significance level set at 0.05.